Logo
Loading location...

Menu

Medicines Diagnosticsscanai Login Signup
Gefimipsa 250mg Capsule is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.Gefimipsa 250mg Capsule should be taken in a dose as recommended by the doctor. You should continue to take it as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. Your doctor may advice for regular monitoring of liver function while your taking this medicine.Common side effects include diarrhea, dry skin, loss of appetite, and nausea. Drink plenty of fluids to reduce the risk of side effects. Inform your doctor if any of the side effects bother you or get worse. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor.Women who are undergoing treatment should use effective contraception method. It is important to avoid pregnancy during the treatment and for a month after completing the course of medicine. Let your doctor also know about all the other medications you are taking.

Salts


More details

Alcohol: It is unsafe to consume alcohol with Gefimipsa 250mg Capsule. Pregnancy: Gefimipsa 250mg Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor. Breastfeeding: Gefimipsa 250mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Driving: Gefimipsa 250mg Capsule may cause side effects which could affect your ability to drive. Kidney: Gefimipsa 250mg Capsule should be used with caution in patients with severe kidney disease. Dose adjustment of Gefimipsa 250mg Capsule may be needed. Please consult your doctor. Liver: Gefimipsa 250mg Capsule is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Gefimipsa 250mg Capsule may not be needed in these patients. Please consult your doctor.

0

Ark Life Sciences Pvt Ltd

0

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youҀ™re worried about them Common Side Effects : Diarrhea Dry skin Loss of appetite Nausea Rash Vomiting Weakness Weight loss Eating disorder Allergic reaction

VARIENTS

    SUBSTITUTES